NCT07727772

Brief Summary

This prospective observational cohort study will enroll adult patients undergoing cardiac surgery at Nanjing First Hospital, Nanjing Medical University. The study will evaluate multidimensional vascular aging markers before surgery and assess their association with postoperative acute kidney injury within 7 days after surgery. No intervention will be assigned by the study protocol, and all perioperative management will follow routine clinical practice.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
472

participants targeted

Target at P75+ for all trials

Timeline
15mo left

Started Jul 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress17%
Jul 2026Dec 2027

Study Start

First participant enrolled

July 1, 2026

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

July 22, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 27, 2026

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 21, 2027

Expected
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 28, 2027

Last Updated

July 27, 2026

Status Verified

July 1, 2026

Enrollment Period

8 months

First QC Date

July 22, 2026

Last Update Submit

July 22, 2026

Conditions

Keywords

vascular agingacute kidney injurypostoperative complications

Outcome Measures

Primary Outcomes (1)

  • Incidence of Postoperative Acute Kidney Injury Within 7 Days After Surgery

    Postoperative acute kidney injury will be assessed within 7 days after surgery according to predefined diagnostic criteria based on postoperative renal function changes. The outcome will be recorded as the occurrence of acute kidney injury during the postoperative 7-day period.

    From the date of surgery to postoperative day 7

Secondary Outcomes (1)

  • Severity of Postoperative Acute Kidney Injury

    From the date of surgery to postoperative day 7

Study Arms (1)

Cardiac Surgery Cohort

Adult patients undergoing cardiac surgery at Nanjing First Hospital who will receive perioperative vascular aging assessment and postoperative renal function monitoring according to the study protocol. No treatment or perioperative management strategy will be assigned by the study protocol.

Other: Multidimensional Vascular Aging Assessment

Interventions

Perioperative assessment of vascular aging-related indicators, including noninvasive vascular assessments, hemodynamic measurements, and relevant clinical and laboratory variables. The assessment is observational and will not determine the treatment, surgical procedure, or perioperative management assigned to participants.

Cardiac Surgery Cohort

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population will consist of adult patients undergoing cardiac surgery at Nanjing First Hospital, Nanjing Medical University. Eligible patients will receive perioperative vascular aging assessment and postoperative renal function monitoring according to the study protocol. Participants will be followed for postoperative acute kidney injury within 7 days after surgery.

You may qualify if:

  • Adult patients aged 18 years or older.
  • Patients scheduled to undergo cardiac surgery at Nanjing First Hospital, Nanjing Medical University.
  • Patients who are able to provide written informed consent.
  • Patients who are expected to undergo perioperative vascular aging assessment and postoperative renal function monitoring according to the study protocol.

You may not qualify if:

  • Patients younger than 18 years.
  • Patients with preoperative end-stage renal disease or maintenance dialysis.
  • Patients who are unable to complete the study-specified vascular aging assessment.
  • Patients who decline participation or withdraw informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nanjing First Hospital, Nanjing Medical University

Nanjing, Jiangsu, 210006, China

Location

MeSH Terms

Conditions

Postoperative ComplicationsAcute Kidney Injury

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 22, 2026

First Posted

July 27, 2026

Study Start

July 1, 2026

Primary Completion (Estimated)

February 21, 2027

Study Completion (Estimated)

December 28, 2027

Last Updated

July 27, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be publicly shared because the study involves clinical data from hospitalized patients and data sharing is restricted by institutional policies and participant privacy protection requirements. De-identified aggregate results may be made available in publications.

Locations